Down-regulation of circular RNA ITCH and circHIPK3 in gastric cancer tissues
- PMID: 30866608
- PMCID: PMC7018364
- DOI: 10.3906/sag-1806-50
Down-regulation of circular RNA ITCH and circHIPK3 in gastric cancer tissues
Abstract
Background/aim: Gastric cancer (GC) is one of the major causes of cancer mortality worldwide. As a novel type of endogenous noncoding RNAs, circular RNAs (circRNAs) are formed by a covalent link between 5’ and 3’ ends. They are very stable and abundant in eukaryotes. As there were no reported studies on the expression profiles of circular RNA ITCH (cir-ITCH) and circHIPK3 in GC, in the current study, we aimed to delineate the expression profiles and clinicopathological relevance of these two circRNAs in GC tissues compared to their paired adjacent noncancerous tissues.
Materials and methods: Quantitative real-time polymerase chain reaction was performed to evaluate cir_ITCH and circHIPK3 expression in 30 paired gastric cancer tissues. The clinicopathological relevance of these two circular RNAs’ expression levels with gastric cancer was further examined.
Results: Our results showed that the expression of cir_ITCH and circHIPK3 were significantly downregulated in GC tumoral tissues compared with their paired adjacent nonneoplastic counterparts. Further analyses showed that cir_ITCH and circHIPK3 expression levels were related with numerous clinicopathological features of tumoral tissues.
Conclusion: Cir_ITCH and circHIPK3 may have imperative roles in GC and serve in the future as potential prognostic biomarkers in GC.
Keywords: Gastric cancer; circular RNAs; cir_ITCH; circHIPK3; gene expression.
Conflict of interest statement
none declared
Figures
Similar articles
-
Circular RNA-ITCH Suppresses Lung Cancer Proliferation via Inhibiting the Wnt/β-Catenin Pathway.Biomed Res Int. 2016;2016:1579490. doi: 10.1155/2016/1579490. Epub 2016 Aug 24. Biomed Res Int. 2016. PMID: 27642589 Free PMC article.
-
Upregulation of circHIPK3 promotes the progression of gastric cancer via Wnt/β-catenin pathway and indicates a poor prognosis.Eur Rev Med Pharmacol Sci. 2019 Sep;23(18):7905-7912. doi: 10.26355/eurrev_201909_19004. Eur Rev Med Pharmacol Sci. 2019. PMID: 31599413
-
Comprehensive circular RNA expression profiles and the tumor-suppressive function of circHIPK3 in ovarian cancer.Int J Biochem Cell Biol. 2019 Jul;112:8-17. doi: 10.1016/j.biocel.2019.04.011. Epub 2019 Apr 23. Int J Biochem Cell Biol. 2019. PMID: 31026505
-
Emerging landscape of circHIPK3 and its role in cancer and other diseases (Review).Mol Med Rep. 2021 Jun;23(6):409. doi: 10.3892/mmr.2021.12048. Epub 2021 Mar 31. Mol Med Rep. 2021. PMID: 33786629 Free PMC article. Review.
-
Circular RNA ITCH: A novel tumor suppressor in multiple cancers.Life Sci. 2020 Aug 1;254:117176. doi: 10.1016/j.lfs.2019.117176. Epub 2019 Dec 13. Life Sci. 2020. PMID: 31843532 Review.
Cited by
-
CircRNA ITCH: Insight Into Its Role and Clinical Application Prospect in Tumor and Non-Tumor Diseases.Front Genet. 2022 Jul 15;13:927541. doi: 10.3389/fgene.2022.927541. eCollection 2022. Front Genet. 2022. PMID: 35910224 Free PMC article. Review.
-
Circular RNA CircHIPK3 Promotes Gemcitabine Sensitivity in Bladder Cancer.J Cancer. 2020 Jan 22;11(7):1907-1912. doi: 10.7150/jca.39722. eCollection 2020. J Cancer. 2020. PMID: 32194801 Free PMC article.
-
Emerging roles of the HECT E3 ubiquitin ligases in gastric cancer.Pathol Oncol Res. 2023 Feb 7;29:1610931. doi: 10.3389/pore.2023.1610931. eCollection 2023. Pathol Oncol Res. 2023. PMID: 36825281 Free PMC article. Review.
-
CircHIPK3 overexpression accelerates the proliferation and invasion of prostate cancer cells through regulating miRNA-338-3p.Onco Targets Ther. 2019 May 2;12:3363-3372. doi: 10.2147/OTT.S196931. eCollection 2019. Onco Targets Ther. 2019. PMID: 31118688 Free PMC article.
-
CircHIPK3 Alleviates High Glucose Toxicity to Human Renal Tubular Epithelial HK-2 Cells Through Regulation of miR-326/miR-487a-3p/SIRT1.Diabetes Metab Syndr Obes. 2021 Feb 17;14:729-740. doi: 10.2147/DMSO.S289624. eCollection 2021. Diabetes Metab Syndr Obes. 2021. PMID: 33628038 Free PMC article.
References
-
- Keeney S Bauer TL Epidemiology of adenocarcinoma of the esophagogastric junction. Surg Oncol Clin N Am. 2006;15:687. - PubMed
-
- Malekzadeh R Derakhshan MH Gastric cancer in Iran: epidemiology and risk factors. Arch Iran Med. 2009;12:576. - PubMed
-
- Mousavi SM Gouya MM Ramazani R Davanlou M Hajsadeghi N Cancer incidence and mortality in Iran. Ann Oncol. 2009;20:556. - PubMed
-
- Kolahdoozan S Sadjadi A Radmard AR Khademi H Five common cancers in Iran. Arch Iran Med. 2010;13:143. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous